Sie suchten nach: gyrase (Dänisch - Englisch)

dna-gyrase
dna gyrase

revers gyrase
reverse gyrase

difloxacin virker primært via hæmning af bakterielt dna-gyrase.
difloxacin acts primarily through inhibition of bacterial dna gyrase.

enzymet dna- gyrase spiller en essentiel rolle i denne proces.
the enzyme dna-gyrase plays a crucial role in this process.

27 som for andre gyrase hæmmere kan ciprofloxacin foranledige ledskader i vækstfasen hos unge dyr.
like with other gyrase inhibitors, ciprofloxacin may induce joint damage during the growth phase of juvenile animals.

difloxacinhydrochlorid virker baktericidt og virker primært ved hæmning af bakteriel dna-gyrase.
difloxacin hydrochloride can be bactericidal in activity and acts primarily through inhibition of bacterial dna gyrase.

som ved andre gyrase- inhibitorer kan ciprofloxacin fremkalde ledskader hos unge dyr i vækstfasen.
like with other gyrase inhibitors, ciprofloxacin may induce joint damage during the growth phase of juvenile animals.

ibafloxacin er et bredspektret antibiotikum med baktericid virkning grundet hæmning af bakteriel dna-gyrase.
ibafloxacin is a broad spectrum antibiotic with bactericidal action resulting from inhibition of bacterial dna gyrase.

de primære targets for pradofloxacin er det bakterielle dna-gyrase og topoisomerase iv-enzymer.
the primary targets for pradofloxacin are the bacterial dna gyrase and topoisomerase iv enzymes.

qj 01 ma 96 ibafloxacin er et bredspektret antibiotikum med baktericid virkning grundet hæmning af bakteriel dna- gyrase.
qj 01 ma 96 ibafloxacin is a broad spectrum antibiotic with bactericidal action resulting from inhibition of bacterial dna gyrase.

det fototoksiske, fotomutagenene og fotocarcinogene potentiale af ciprofloxacin er sammenlignelig med det, der gælder for andre gyrase inhibitorer.
the phototoxic, photomutagenic and photocarcinogenic potential of ciprofloxacin is comparable to that of other gyrase inhibitors.

der kan udvikles resistens mod quinoloner ved mutationer i bakteriernes gyrase-gen og ved ændringer i cellernes permeabilitet overfor quinoloner.
induction of resistance against quinolones can develop by mutations in the gyrase gene of bacteria and by changes in cell permeability towards quinolones

ved at blokere dna-gyrase forhindrer ibafloxacin bakterierne i at producere dna og standser deres proteinproduktion og vækst, så de dør.
by blocking dna gyrase, ibafloxacin prevents the bacteria from making dna and stops them making proteins and growing, resulting in their death.

ved at blokere dna-gyrase forhindrer orbifloxacin bakterierne i at danne dna og stopper deres produktion af proteiner og deres vækst, så de dør.
by blocking dna gyrase, orbifloxacin prevents the bacteria from making dna and stops them making proteins and growing, resulting in their death.

ciprofloxacin har en hurtigt indsættende baktericid virkning, der skyldes hæmning af dna- gyrase og deraf følgende hæmning af dna- syntesen.
ciprofloxacin exerts a rapid bactericidal effect by inhibiting dna-gyrase, resulting in inhibition of dna synthesis.

ciprofloxacin har en hurtigt indsættende baktericid virkning, der beror på hæmning af dna- gyrase og deraf følgende hæmning af dna- syntesen.
ciprofloxacin exerts a rapid bactericidal effect by inhibiting dna-gyrase, resulting in inhibition of dna synthesis.

det virker ved at blokere et enzym kaldet ”dna-gyrase”, som er vigtigt for at bakterier kan lave kopier af deres dna.
it works by blocking an enzyme called ‘dna gyrase’, which is important in allowing bacteria to make copies of their dna.

in vitro- resistens mod moxifloxacin udvikles langsomt via trinvise processer medieret af target- site - mutationer i begge type ii topoisomeraser, dna gyrase og topoisomerase iv.
in vitro resistance to moxifloxacin is acquired through a stepwise process by target site mutations in both type ii topoisomerases, dna gyrase and topoisomerase iv.

difloxacin virker ved at blokere et enzym kaldet "dna-gyrase", som spiller en vigtig rolle for, at bakterier kan lave kopier af deres eget dna.
difloxacin works by blocking an enzyme called ‘dna gyrase’, which is important in allowing bacteria to make copies of their dna.

orbifloxacins baktericide virkning skyldes hæmning af enzymerne dna- topoisomerase ii (dna-gyrase) og dna- topoisomerase iv, som er nødvendige for dannelsen og vedligeholdelsen af bakterielt dna.
the bactericidal action of orbifloxacin results from interference with the enzymes dna topoisomerase ii (dna-gyrase) and dna topoisomerase iv which are needed for the synthesis and maintenance of bacterial dna.